Changeflow GovPing Pharma & Drug Safety EPO Patent Publication: Fecal Microbiome Spatia...
Routine Notice Added Final

EPO Patent Publication: Fecal Microbiome Spatial Characterization

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026030670A1 concerning the spatial characterization of the fecal microbiome. The publication date is March 18, 2026, and it includes various International Patent Classifications related to biotechnology and medical applications.

What changed

The European Patent Office (EPO) has published a new patent application, EP2026030670A1, related to the spatial characterization of the fecal microbiome. The publication date is March 18, 2026. The application includes several International Patent Classifications (IPCs) such as G06T 7/00, A61K 35/74, C12N 1/20, C12Q 1/6816, and G16H 30/40, indicating its relevance to imaging, biotechnology, and health informatics.

This publication represents the initial disclosure of the patent application. As it is a patent publication and not a regulatory rule or enforcement action, there are no immediate compliance obligations or deadlines for regulated entities. However, companies in the biotechnology, pharmaceutical, and healthcare sectors may wish to monitor the progress of this patent application through the EPO examination process, as granted patents can confer exclusive rights and impact market exclusivity for related products or technologies.

Source document (simplified)

← EPO Patent Bulletin

SPATIAL CHARACTERIZATION OF THE FECAL MICROBIOME

Publication EP2026030670A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

G06T 7/00 20170101AFI20260208BHEP A61K 35/74 20150101ALI20260208BHEP C12N 1/20 20260101ALI20260208BHEP C12N 1/04 20060101ALI20260208BHEP C12Q 1/6816 20180101ALI20260208BHEP C12Q 1/6841 20180101ALI20260208BHEP C12Q 1/6876 20180101ALI20260208BHEP G16H 30/40 20180101ALI20260208BHEP G16H 50/00 20180101ALI20260208BHEP A23L 33/135 20160101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030670A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Biotechnology Research Medical Diagnostics
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Biotechnology Medical Research

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.